Finance Biogen Stock: Biogen Announces $7.3 Billion Acquisition Of Reata PharmaceuticalsJuly 28, 20230 Biogen (BIIB) introduced Friday it has agreed to amass Reata Prescription drugs (RETA) for about $7.3 billion, boosting biopharmaceutical firm…
